Manufacturer record
Medline Pharmaceuticals Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Medline Pharmaceuticals Pvt Ltd (Tamil Nadu) were declared Not of Standard Quality between March 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MBM 18, Basm Multi-Spectrum Expectorant (exp Aug 2027). Drugs Testing Laboratory, Chennai-06 (state lab) found it not of standard quality: Content. Listed in the December 2025 alert.
Records by type
2 records linked to Medline Pharmaceuticals Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Basm Multi-Spectrum Expectorant | Batch MBM 18Mfg Sep 2025 · Exp Aug 2027 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Dec 2025 |
| Vitamin A, Vitamin D3, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Calcium Pantothanate, Niacinamide, Vitamin C & Folic Acid Tablets | Batch GMB 21Mfg Mar 2021 · Exp Aug 2022 | Description & Assay of ?Vitamin D3?, ?Riboflavin?, & ?Calcium Pantothanate?.Assay | CDL KolkataCDSCO lab | Mar 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.